133 related articles for article (PubMed ID: 19913568)
1. New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.
Cabeza M; García-Lorenzana M; Garcés M; Heuze I; Teran N; Bratoeff E
Steroids; 2010 Jan; 75(1):101-8. PubMed ID: 19913568
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
3. Novel phosphorus-containing 17beta-side chain mifepristone analogues as progesterone receptor antagonists.
Jiang W; Allan G; Chen X; Fiordeliso JJ; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Sui Z
Steroids; 2006 Nov; 71(11-12):949-54. PubMed ID: 16934845
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of androstene derivatives.
Garrido M; Bratoeff E; García-Lorenzana M; Heuze Y; Soriano J; Valencia N; Cortes F; Cabeza M
Arch Pharm (Weinheim); 2013 Jan; 346(1):62-70. PubMed ID: 23208946
[TBL] [Abstract][Full Text] [Related]
5. The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression.
Gordon A; Garrido-Gracia JC; Aguilar R; Bellido C; Velasco JA; Millan Y; Tena-Sempere M; Martín de Las Mulas J; Sánchez-Criado JE
J Endocrinol; 2008 Mar; 196(3):583-92. PubMed ID: 18310454
[TBL] [Abstract][Full Text] [Related]
6. Antiprogestins: mechanism of action and contraceptive potential.
Spitz IM; Croxatto HB; Robbins A
Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.
Attardi BJ; Burgenson J; Hild SA; Reel JR
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):277-88. PubMed ID: 15120421
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptors in coeliac ganglion in late pregnant rat.
Vallcaneras SS; Casais M; Delgado SM; Filippa V; Mohamed F; Sosa Z; Rastrilla AM
Steroids; 2009 Jun; 74(6):526-34. PubMed ID: 19428441
[TBL] [Abstract][Full Text] [Related]
9. Contraception with LHRH agonists, a new physiological approach.
Labrie F; Séguin C; Bélanger A; Lefebvre FA; Massicotte J; Kelly PA; Pelletier G; Reeves JJ; Lemay A; Cusan L; Raynaud JP
Reproduccion; 1981; 5(4):229-41. PubMed ID: 6274723
[TBL] [Abstract][Full Text] [Related]
10. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
[TBL] [Abstract][Full Text] [Related]
11. Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function.
Shao R; Weijdegård B; Ljungström K; Friberg A; Zhu C; Wang X; Zhu Y; Fernandez-Rodriguez J; Egecioglu E; Rung E; Billig H
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E59-72. PubMed ID: 16449295
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor antagonists and the endometrial antiproliferative effect.
Brenner RM; Slayden OD
Semin Reprod Med; 2005 Feb; 23(1):74-81. PubMed ID: 15714391
[TBL] [Abstract][Full Text] [Related]
13. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of novel nonsteroidal progesterone receptor antagonists derived from the fungal metabolite PF1092C.
Tabata Y; Iizuka Y; Masuda NT; Shinei R; Kurihara Ki; Okonogi T; Hoshiko S; Kurata Y
J Steroid Biochem Mol Biol; 2002 Oct; 82(2-3):217-23. PubMed ID: 12477488
[TBL] [Abstract][Full Text] [Related]
15. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antihormonal properties of novel 11β-benzoxazole-substituted steroids.
Jin C; Fix SE; Kepler JA; Cook CE
Bioorg Med Chem Lett; 2012 Feb; 22(4):1705-8. PubMed ID: 22260770
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor antagonists.
Spitz IM
Curr Opin Investig Drugs; 2006 Oct; 7(10):882-90. PubMed ID: 17086932
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of prostaglandin F 2 by the ovary and uterus.
Wilks JW; Forbes KK; Norland JF
J Reprod Med; 1972 Dec; 9(6):271-6. PubMed ID: 4630792
[No Abstract] [Full Text] [Related]
19. Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
Rey-Roldán EB; Grillo CA; Pietranera L; Libertun C; Nicola AF; Piroli GG
Horm Metab Res; 2008 Apr; 40(4):245-50. PubMed ID: 18548383
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists.
Kang FA; Allan G; Guan J; Jain N; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Chen X; Demarest K; Lundeen S; Sui Z
Bioorg Med Chem Lett; 2007 Feb; 17(4):907-10. PubMed ID: 17169557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
